Affordable Access

Access to the full text

Chronic rhinosinusitis and premorbid autoimmune diseases: a population-based case–control study

Authors
  • Shih, Liang-Chun1, 2, 1
  • Hsieh, Hua-Hsin1
  • Tsay, Gregory J.1
  • Lee, Ivan T.3
  • Tsou, Yung-An1, 2
  • Lin, Cheng-Li1
  • Shen, Te-Chun1, 2, 4
  • Bau, Da-Tian2, 1
  • Tai, Chih-Jaan1, 2
  • Lin, Chia-Der1, 2, 2
  • Tsai, Ming-Hsui1, 2, 2
  • 1 China Medical University Hospital, Taichung, 40447, Taiwan , Taichung (Taiwan)
  • 2 China Medical University, Taichung, 40447, Taiwan , Taichung (Taiwan)
  • 3 Stanford University School of Medicine, Stanford, CA, 94305, USA , Stanford (United States)
  • 4 China Medical University Hospital, No. 2, Yude Rode, Taichung, 40447, Taiwan , Taichung (Taiwan)
Type
Published Article
Journal
Scientific Reports
Publisher
Springer Nature
Publication Date
Oct 29, 2020
Volume
10
Issue
1
Identifiers
DOI: 10.1038/s41598-020-75815-x
Source
Springer Nature
License
Green

Abstract

Evidence shows that chronic rhinosinusitis (CRS) is associated with prior presence of autoimmune diseases; however, large-scale population-based studies in the literature are limited. We conducted a population-based case–control study investigating the association between CRS and premorbid autoimmune diseases by using the National Health Insurance Research Database in Taiwan. The CRS group included adult patients newly diagnosed with CRS between 2001 and 2013. The date of diagnosis was defined as the index date. The comparison group included individuals without CRS, with 1:4 frequency matching for gender, age, and index year. Premorbid diseases were forward traced to 1996. Univariate and multivariate logistic regression was performed to estimate odds ratios (ORs) and 95% confidence intervals. The CRS group consisted of 30,611 patients, and the comparison group consisted of 122,444 individuals. Patients with CRS had a higher significant association with premorbid autoimmune diseases (adjusted OR 1.39 [1.28–1.50]). Specifically, patients with CRS had a higher significant association with ankylosing spondylitis, polymyositis, psoriasis, rheumatoid arthritis, sicca syndrome, and systemic lupus erythematosus (adjusted OR 1.49 [1.34–1.67], 3.47 [1.12–10.8], 1.22 [1.04–1.43], 1.60 [1.31–1.96], 2.10 [1.63–2.72], and 1.69 [1.26–2.25]). In subgroup analysis, CRS with and without nasal polyps demonstrated a significant association with premorbid autoimmune diseases (adjusted OR 1.34 [1.14–1.58] and 1.50 [1.38–1.62]). In addition, CRS with fungal and non-fungal infections also demonstrated a significant association with premorbid autoimmune diseases (adjusted OR 2.02 [1.72–2.49] and 1.39 [1.28–1.51]). In conclusion, a significant association between CRS and premorbid autoimmune diseases has been identified. These underlying mechanisms need further investigation.

Report this publication

Statistics

Seen <100 times